Skip to contentK
Kewaunee Scientific Corp
K
KEQUKewaunee Scientific Corp Q1 2020 · 10-Q
Revenue$39.34M$39.34M−6.7% vs Q1 2019 Net Income$471.00K$471.00K−66.5% vs Q1 2019 EPS Diluted$0.17$0.17−67.9% vs Q1 2019 Gross Profit$6,946,000−8.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kewaunee Scientific Corp · CIK 55529 · Engraved from SEC EDGAR
Operating Cash Flow-$407,000N/M Free Cash Flowderived-$1,590,000N/M Margins · derivedGross margin17.7%−0.3 pt vs Q1 2019
Operating margin2.0%−2.3 pt vs Q1 2019
Net margin1.2%−2.1 pt vs Q1 2019
ended Jul 31, 2019 · filed Sep 6, 2019 · 37 d after period end